Aqtual

Hayward, United States

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease.

$31.0M raised

Jul 2025

Series B

Top Investors

Genoa VenturesBold Capital PartnersManta Ray VenturesYu GalaxyBOLD Longevity Growth Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Aqtual raised?

Aqtual has raised $31.0M in total funding. The most recent round was Series B. The last funding was announced in July 2025.

Who are Aqtual's investors?

Aqtual's investors include Genoa Ventures, Bold Capital Partners, Manta Ray Ventures, Yu Galaxy, BOLD Longevity Growth Fund.

Where is Aqtual headquartered?

Aqtual is headquartered in Hayward, United States.

What does Aqtual do?

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease.

What stage is Aqtual at?

Aqtual is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 10, 2025.

MLA

"Aqtual — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/aqtual. Accessed June 17, 2026.

APA

VCBacked. (2025). Aqtual — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/aqtual

Wikipedia (cite web)

{{cite web |title=Aqtual — Funding & Investors |url=https://www.vcbacked.co/company/aqtual |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 10, 2025.